The History of WuXi AppTec

About WuXi AppTec  

In the early 2000s, the pharmaceutical industry needed partners who could combine scientific rigor with speed and global scale. WuXi AppTec was established to meet that need—serving as an enabler within the pharmaceutical ecosystem, partnering with innovators to lower R&D costs, and accelerating the path from discovery to patients. 

Founding

WuXi AppTec was established in 2000 by four co-founders and a 7,000 square-foot laboratory with the belief that every drug can be made, and every disease can be treated.
 

      The first lab at WuXi AppTec

            The first fume hood at WuXi AppTec

Upholding the Highest Global Standards

For 25 years, WuXi AppTec has remained committed to helping customers advance life science discovery and deliver treatments to those in need.

WuXi AppTec's service platform was built to meet the stringent requirements of both customers and regulatory authorities. WuXi AppTec has received regulatory approvals from agencies in the U.S., EU, Australia, Canada, China, Japan, New Zealand, and Switzerland. The company maintains the highest standards for intellectual property protection, data security, and privacy, and operates in compliance with applicable laws and regulations across all jurisdictions in which it operates.

Service Expansion in Early Years

Starting with laboratory chemical synthesis, WuXi AppTec progressively expanded its services to biology and testing, and from the early stage of drug discovery all the way to commercialization and manufacturing.

Global Growth 

WuXi AppTec's global network of sites across Asia, Europe, and the U.S. allows the company to support customers across therapeutic areas and time zones, providing continuity and flexibility throughout the drug development process.

Integrated Contract, Research, Development, Manufacturing Organization (CRDMO) Platform

Today, WuXi AppTec supports customers across the full spectrum of drug R&D and manufacturing.

Through its fully integrated CRDMO model—spanning every stage of drug development, a wide range of modalities, and a global footprint that stretches across Asia, Europe, and the U.S.—the company enables seamless transitions and accelerates the path from idea to medicine.

Role in the Global Healthcare Community

  Active Contributor to Our Global Communities

Being part of the global healthcare community, WuXi AppTec's role goes beyond service delivery – the company is humbled to support and sustain innovation ecosystems by linking startups, investors, and industry.

Through leading conferences and professional events, WuXi AppTec unites thousands of global leaders and entrepreneurs each year, strengthening collaboration across borders and across disciplines to help make innovation accessible to all.

WuXi AppTec Today

WuXi AppTec is proud of how far it has come. But it is even more excited about what lies ahead.

As science accelerates and technologies converge, the company stands ready—with its global platform, its passionate people, and its enduring values—to help shape the future of healthcare.

As drug development becomes more complex and globally distributed, WuXi AppTec's integrated CRDMO platform — spanning discovery, development, and manufacturing across Asia, Europe, and the U.S. — is designed to help partners move faster so treatments can reach patients sooner.